Found 13 matching trials
Single-dose Novel Selective alpha2c Antagonist Pharmaco-MRI Study in Healthy Volunteers
PHASE1The aim of the present study is to investigate changes in neural activity (...
Location
UCT Dept. Psychiatry & Mental Health / CUBIC
Pharmacokinetic Study of Multiple Doses of ORM-12741 (Nebula PK 2)
PHASE1The purpose of this study is to evaluate ORM-12741 concentrations in blood ...
Location
Clinical Research Services Turku - CRST Oy
Pharmacokinetic Study of ORM-12741 in Healthy Volunteers
PHASE1The purpose of this study is to determine pharmacokinetic parameters of ORM...
Safety and Efficacy of ORM-12741 in Patients With Alzheimer's Disease
PHASE2The purpose of this study is to determine whether ORM-12741 is safe and eff...
Location
Clinical Research Services Turku (CRST)
Efficacy of ORM-12741 for Prevention of Raynaud's Phenomenon
PHASE2Raynaud's phenomenon (RP) is a disorder of the digital blood vessels result...
Location
Salford Royal NHS foundation Trust
Excretion Balance and Metabolism After a Single Oral Dose of 14C-Labelled ORM-12741
PHASE1The study is conducted to examine absorption of C14-ORM-12741 from intestin...
Location
PRA International
Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease
PHASE2This study evaluates the effect of ORM-12741 on agitation/aggression sympto...
Location
Clinical Research Services Turku - CRST Oy
Early Phase I Microdosing Study of ORM-14540 and ORM-12741
EARLY_PHASE1The purpose of this study is to determine pharmacokinetic parameters of ORM...
Pharmacokinetic Study of Single Doses of ORM-12741
PHASE1The purpose of this study is to evaluate ORM-12741 concentrations in the bl...
Location
Clinical Research Services Turku, CRST
A PET Study With ORM-12741
PHASE1The purpose of the study is to evaluate the effect of ORM-12741 on receptor...